These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1967 related items for PubMed ID: 24262616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A, ISAR-LEFT MAIN Study Investigators.
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M, Kimura T, Morimoto T, Hayashi Y, Shiode N, Nishikawa H, Nakao K, Shirota K, Kawai K, Hiasa Y, Kadota K, Nozaki Y, Isshiki T, Sone T, Mitsudo K, j-Cypher Registry Investigators.
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):976-83. PubMed ID: 17295334
    [Abstract] [Full Text] [Related]

  • 8. Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
    Džavík V, Kaul U, Guagliumi G, Chevalier B, Smits PC, Stuteville M, Li D, Sudhir K, Grube E.
    Catheter Cardiovasc Interv; 2013 Sep 01; 82(3):E163-72. PubMed ID: 23225766
    [Abstract] [Full Text] [Related]

  • 9. 5-Year clinical follow-up of the COBRA (complex coronary bifurcation lesions: Randomized comparison of a strategy using a dedicated self-expanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study.
    Bennett J, Adriaenssens T, McCutcheon K, Dens J, Desmet W, Sinnaeve P, Vrolix M, Dubois C.
    Catheter Cardiovasc Interv; 2018 Nov 15; 92(6):E375-E380. PubMed ID: 29536609
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M, Schröder J, Pross V, Marx N, Hoffmann R.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):881-7. PubMed ID: 23765557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL.
    Cardiovasc Ther; 2013 Aug 01; 31(4):193-200. PubMed ID: 22954234
    [Abstract] [Full Text] [Related]

  • 15. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1138-46. PubMed ID: 22422607
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 17. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting.
    Pan M, Medina A, Suárez de Lezo J, Romero M, Segura J, Martín P, Suárez de Lezo J, Hernandez E, Mazuelos F, Ojeda S.
    Catheter Cardiovasc Interv; 2012 Dec 01; 80(7):1165-70. PubMed ID: 22511299
    [Abstract] [Full Text] [Related]

  • 18. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
    Kufner S, Byrne RA, Mehilli J, Massberg S, Birkmeier KA, Schulz S, Pache J, Schömig A, Kastrati A.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):E769-76. PubMed ID: 23754254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 99.